Cravath and Lenz & Staehelin represented Taro in connection with the transaction. Ropes & Gray advised Galderma. Taro Pharmaceutical Industries Ltd. (“Taro”), a multinational, science-based pharmaceutical...
Taro Pharmaceutical Industries’ Acquisition of Alchemee
IBM’s Acquisition of Sentaca
Cravath represented IBM in the transaction. IBM announced it has acquired Sentaca, a leading telco consulting services and solutions provider. Sentaca will join IBM Consulting’s Hybrid...
Vaxxinity’s $89.7 Million Initial Public Offering
Cravath represented Vaxxinity in the transaction. Vaxxinity, Inc. executed its initial public offering of 6,000,000 shares of class A common stock at a public offering price of $13.00...
Goldman Sachs’ $2.24 Billion Acquisition of GreenSky
Simpson Thacher advised J.P. Morgan Securities on the deal, while Cravath represented GreenSky. The Goldman Sachs Group executed its acquisition of GreenSky, the largest fintech platform for home improvement...
Swvl’s Merger with Queen’s Gambit Growth Capital
Orrick Herrington & Sutcliffe advised VNV Global on the deal, while Vinson & Elkins, Shahid and Walkers represented Queen’s Gambit Growth Capital. Cravath, Swaine & Moore...
Convey Holding Parent’s $186.7 Million Initial Public Offering
Cravath represented Convey Holding Parent, while Davis Polk advised the representatives of the several underwriters in the offering. Convey Holding Parent, Inc. (“Convey Health”) executed the $186.7...
Ventas’ $2.3 Billion Acquisition of New Senior Investment Group
Wachtell, Lipton, Rosen & Katz, Davis Polk represented Ventas, while Cravath, Swaine & Moore LLP represented New Senior in the transaction. Fried Frank acted as counsel...